UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P114 Characteristics of residual tumor after neoadjuvant chemotherapy (nact)may predict outcomes in patients with triple negative breast cancer (tnbc)

Breast (Edinburgh), 2023-04, Vol.68, p.S58-S58

2023

Volltextzugriff (PDF)

Ordinal classification using Pareto fronts

Expert systems with applications, 2015-08, Vol.42 (14), p.5947-5953

2015

Volltextzugriff (PDF)

Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients

Bulletin of experimental biology and medicine, 2021-10, Vol.171 (6), p.755-759

2021

Volltextzugriff (PDF)

Expansion of the γδT cell population in peripheral blood: a response of immune system to the damage of gastrointestinal mucous membranes in older age groups

Medit͡s︡inskai͡a︡ immunologii͡a, 2024-11, Vol.26 (6), p.1315-1321

2024

Volltextzugriff (PDF)

Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy

Bulletin of experimental biology and medicine, 2020-08, Vol.169 (4), p.486-490

2020

Volltextzugriff (PDF)

Dual anti-HER2 blockade in late-line treatment of metastatic HER2-positive breast cancer

Medicinskij sovet, 2021-12 (20), p.156-159

2021

Volltextzugriff (PDF)

A new approach to immunosuppressive therapy in patients with glomerulonephritis with nephrotic syndrome

Medit͡s︡inskai͡a︡ immunologii͡a, 2024-01, Vol.26 (1), p.181-190

2024

Volltextzugriff (PDF)

Clinical case of the use of oral metronomic vinorelbin in patient with metastatic Her2 negative breast cancer

Medicinskij sovet, 2021-08 (9), p.148-153

2021

Volltextzugriff (PDF)

PARP inhibitors in the treatment of metastatic breast cancer patients with germline BRCA1/2 mutations. Experience of treatment with talazoparib in clinical practice

Medicinskij sovet, 2020-07 (9), p.57-61

2020

Volltextzugriff (PDF)

Selecting an optimal model for forecasting the volumes of railway goods transportation

Automation and remote control, 2017, Vol.78 (1), p.75-87

2017

Volltextzugriff (PDF)

Changes in Serum Levels of Growth Factors in Chronic Gastritis

Vestnik Rossiĭskogo universiteta druzhby narodov. Serii͡a︡ Medit͡s︡ina, 2019-12, Vol.23 (3), p.250-256

2019

Volltextzugriff (PDF)

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case

Medicinskij sovet, 2019-12 (19), p.69-72

2019

Volltextzugriff (PDF)

[OP.2A.09] VARIABILITY OF LENGTH OF TELOMERES IN WOMEN WITH BREAST CANCER AND DIFFERENT HYPERTENSIVE STATUS DURING ANTICANCER TREATMENT

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e14

2017

Volltextzugriff (PDF)

Systemic control of cerebral metastases in a patient with HER2-positive metastatic breast cancer. Clinical case

Medicinskij sovet, 2019-06 (10), p.129-134

2019

Volltextzugriff (PDF)

A84a

European journal of cancer supplements, 2015-11, Vol.13 (1), p.69-70

2015

Volltextzugriff (PDF)

Remote Measurement of Respiratory Rate in Laboratory Mice during Studies of mdx-Model of Progressive Duchenne Muscular Dystrophy

Biomedical engineering, 2015-07, Vol.49 (2), p.79-84

2015

Volltextzugriff (PDF)

Phenotypic Differences between mdx Black Mice and mdx Albino Mice. Comparison of Cytokine Levels in the Blood

Bulletin of experimental biology and medicine, 2013-07, Vol.155 (3), p.376-379

2013

Volltextzugriff (PDF)

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey

Opukholi zhenskoĭ reproduktivnoĭ sistemy, 2021-01, Vol.16 (3), p.37-45

2021

Volltextzugriff (PDF)

Place of fulvestrant in the treatment of patients with metastatic luminal Her2-negative breast cancer

Medicinskij sovet, 2023-07 (11), p.41-47

2023

Volltextzugriff (PDF)

Cytokine profile of the blood in mice with normal and abnormal heart rhythm

Bulletin of experimental biology and medicine, 2012-04, Vol.152 (6), p.692-695

2012

Volltextzugriff (PDF)

Palbociclib in the first line combination hormone therapy of HER2- negative metastatic hormone-dependent breast cancer. Clinical follow-up

Medical Council, 2018-07 (10), p.158-160

2018

Volltextzugriff (PDF)

Real clinical practice patterns of palbociclib usage in Russian Federation

Medicinskij sovet, 2022-12 (22), p.30-35

2022

Volltextzugriff (PDF)

Ribociclib in the first-line therapy for metastatic hormone-dependent HER2-negative breast cancer in patients with intact ovarian function

Medical Council, 2018-11 (19), p.28-30

2018

Volltextzugriff (PDF)

Remote measurement of respiratory rate labratory mice in studies of mdx model of Duchenne muscular dystrophy

Meditsinskaia tekhnika, 2015-03 (2), p.12

2015

Volltextzugriff (PDF)

Clinical case on the use of oral vinorelbine in the treatment of disseminated estrogen receptor-positive HER2-negative breast cancer

РМЖ: Медицинское обозрение, 2021, Vol.5 (8), p.548-551

2021

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(144)
Russisch
(64)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

P114 Characteristics of residual tumor after neoadjuvant chemotherapy (nact)may predict outcomes in patients with triple negative breast cancer (tnbc)

Ordinal classification using Pareto fronts

Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients

Expansion of the γδT cell population in peripheral blood: a response of immune system to the damage of gastrointestinal mucous membranes in older age groups

Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy

Dual anti-HER2 blockade in late-line treatment of metastatic HER2-positive breast cancer

A new approach to immunosuppressive therapy in patients with glomerulonephritis with nephrotic syndrome

Clinical case of the use of oral metronomic vinorelbin in patient with metastatic Her2 negative breast cancer

PARP inhibitors in the treatment of metastatic breast cancer patients with germline BRCA1/2 mutations. Experience of treatment with talazoparib in clinical practice

Selecting an optimal model for forecasting the volumes of railway goods transportation

Changes in Serum Levels of Growth Factors in Chronic Gastritis

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case

[OP.2A.09] VARIABILITY OF LENGTH OF TELOMERES IN WOMEN WITH BREAST CANCER AND DIFFERENT HYPERTENSIVE STATUS DURING ANTICANCER TREATMENT

Systemic control of cerebral metastases in a patient with HER2-positive metastatic breast cancer. Clinical case

A84a

Remote Measurement of Respiratory Rate in Laboratory Mice during Studies of mdx-Model of Progressive Duchenne Muscular Dystrophy

Phenotypic Differences between mdx Black Mice and mdx Albino Mice. Comparison of Cytokine Levels in the Blood

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey

Place of fulvestrant in the treatment of patients with metastatic luminal Her2-negative breast cancer

Cytokine profile of the blood in mice with normal and abnormal heart rhythm

Palbociclib in the first line combination hormone therapy of HER2- negative metastatic hormone-dependent breast cancer. Clinical follow-up

Real clinical practice patterns of palbociclib usage in Russian Federation

Ribociclib in the first-line therapy for metastatic hormone-dependent HER2-negative breast cancer in patients with intact ovarian function

Remote measurement of respiratory rate labratory mice in studies of mdx model of Duchenne muscular dystrophy

Clinical case on the use of oral vinorelbine in the treatment of disseminated estrogen receptor-positive HER2-negative breast cancer

Suchergebnisse filtern